IDEXX Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. 

CEO
Michael Erickson
CEOMichael Erickson
Employees
11,000
Employees11,000
Headquarters
Westbrook, Maine
HeadquartersWestbrook, Maine
Founded
1983
Founded1983
Employees
11,000
Employees11,000

IDXX Key Statistics

Market cap
44.13B
Market cap44.13B
Price-Earnings ratio
41.16
Price-Earnings ratio41.16
Dividend yield
Dividend yield
Average volume
636.22K
Average volume636.22K
High today
$562.30
High today$562.30
Low today
$549.75
Low today$549.75
Open price
$551.46
Open price$551.46
Volume
461.30K
Volume461.30K
52 Week high
$769.98
52 Week high$769.98
52 Week low
$496.61
52 Week low$496.61

Stock Snapshot

As of today, IDEXX Laboratories(IDXX) shares are valued at $559.37. The company's market cap stands at 44.13B, with a P/E ratio of 41.16.

During the trading session on 2026-05-25, IDEXX Laboratories(IDXX) shares reached a daily high of $562.30 and a low of $549.75. At a current price of $559.37, the stock is +1.8% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 461.3K, compared to an average daily volume of 636.22K.

The stock's 52-week range extends from a low of $496.61 to a high of $769.98.

The stock's 52-week range extends from a low of $496.61 to a high of $769.98.

IDXX News

Simply Wall St 2d
IDEXX Laboratories Is Up 5.8% After Embedding SDMA Into Routine Catalyst CLIPs Testing - simplywall.st

...

IDEXX Laboratories Is Up 5.8% After Embedding SDMA Into Routine Catalyst CLIPs Testing - simplywall.st
Simply Wall St 5d
IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate

IDEXX Laboratories (NasdaqGS:IDXX) has integrated the SDMA kidney biomarker into its most widely used Catalyst in-clinic chemistry profiles. The update allows...

IDEXX SDMA Rollout Ties Earlier Kidney Detection To Valuation Debate
TipRanks 6d
Idexx Laboratories announces SDMA to be built into Catalyst CLIPs

IDEXX Laboratories (IDXX) announced that SDMA, a renal biomarker, will be built into Catalyst CLIPs, making complete kidney function evaluation part of the most...

Analyst ratings

47%

of 15 ratings
Buy
46.7%
Hold
46.7%
Sell
6.7%

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.